Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.
Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.
“This is such an exciting topic for all of us,” Rugo said. “It pervades everything […]
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jerry Liuhttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJerry Liu2023-06-19 12:19:552023-06-19 12:20:44PCPA in the news – can ‘smart bombs’ replace chemo?
Pharma News: In an event that showcased the cutting-edge advancements in cancer treatment, the Private Cancer Physicians of Australia (PCPA) joined forces with GenesisCare, their Strategic Alliance Partner, to successfully launch the inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass. This event witnessed healthcare leaders from Gilead Australia immerse themselves in the daily life of breast cancer patients undergoing complex treatments, providing a unique opportunity to gain invaluable insights into the challenges faced by patients and their MDT teams.
Under the esteemed guidance of PCPA Board member and renowned GenesisCare Medical Oncologist, Professor Stephen Clarke, […]
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jerry Liuhttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJerry Liu2023-06-02 14:28:402023-06-02 14:32:11PCPA in the news – Unveiling the power of empathy: Gilead joins oncologists in bridging the gap
PCPA in the news – can ‘smart bombs’ replace chemo?
/in News, PCPA in the news /by Jerry Liupharma in focus 13 June – 16 June 2023
Posted 15 June 2023
Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.
Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.
“This is such an exciting topic for all of us,” Rugo said. “It pervades everything […]
PCPA Media Release – Monday 19 June 2023
/in Media Releases /by Jerry LiuPCPA in the news – Unveiling the power of empathy: Gilead joins oncologists in bridging the gap
/in News, PCPA in the news /by Jerry LiuHealth Industry Hub 26 May 2023
Pharma News: In an event that showcased the cutting-edge advancements in cancer treatment, the Private Cancer Physicians of Australia (PCPA) joined forces with GenesisCare, their Strategic Alliance Partner, to successfully launch the inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass. This event witnessed healthcare leaders from Gilead Australia immerse themselves in the daily life of breast cancer patients undergoing complex treatments, providing a unique opportunity to gain invaluable insights into the challenges faced by patients and their MDT teams.
Under the esteemed guidance of PCPA Board member and renowned GenesisCare Medical Oncologist, Professor Stephen Clarke, […]